Safety and Performance of UCon Patch Electrode

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInnoCon Medical

About this trial

UCon is a medical device for treating the symptoms of overactive bladder (OAB) and bowel dysfunction (BD). It electrically stimulates the DGN through the skin to obtain modulated behavior of the bladder/bowel musculature e.g., suppressing undesired bladder/bowel activity to relieve the symptoms of the patient.

This pivotal clinical investigation is designed as a stratified-randomized, single-blinded, controlled, confirmatory, prospective, multicenter clinical investigation.

Eligibility criteria

Qualifiers

Participant is ≥ 18 years of age.

Participant is diagnosed with OAB or BD.

Participant is able to consent, communicate, provide feedback, and understand and follow instructions in Danish during the course of the investigation, including operation of the device at home.

Disqualifiers

Participant has genital anatomy that does not allow for proper electrode placement or stimulation of the DGN.

Participant has an active infection in the genital area, including skin infections.

Participant has injured or irritated skin in the genital area, where the electrode is placed.

Participant is medically unstable (acute illness or complication of a chronic condition, apart from the OAB or BD, that might affect the participant's participation in the investigation).

Trial design

Treatments tested in this trial

  • Time Limited stimulation
  • Sham stimulation

Treatment groups

180 Participants
are divided into 2 treatment groups

Sponsors and collaborators

InnoCon Medical

Lead sponsor

Aarhus University Hospital

Collaborator

Odense University Hospital

Collaborator

Herlev Hospital

Collaborator